FIGURE

Fig. 7

ID

ZDB-FIG-131009-33

Publication

Foster et al., 2013 - Nuclear phosphatase PPM1G in cellular survival and neural development

Other Figures

All Figure Page

Back to All Figure Page

Fig. 7

ppm1g morphants have central nervous system defects and aberrant expression of brain markers. A,B: Morphology of embryos injected with 6 ng ppm1gMO or control at 36hpf. Morphants also have necrotic tissue in the presumptive telencephalon (B, inset). C,D: Acridine orange staining indicates elevated apoptosis in the forebrain ventricular zone (vz), central nervous system (cns), and anus (a) in the ppm1g morphants at 24 hpf. C2, D2 are insets enlarged from image areas in C and D as indicated. E: Gross morphology of the whole embryos shown in A and B. In situ hybridization signal for pax2 in ppm1g morphant and control. F,G: Abnormal expression of pax2 in the ppm1g morphant was identified in the midbrain tectum mid and hindbrain, mhb, (arrowhead), choroid fissure (cf), and optic nerve. H,I: Dorsal view of in situ hybridization signal for notch1B in the ppm1gmorphant and control.

Expression Data

Gene:	notch1b
Fish:	WT WT + MO1-ppm1g
Knockdown Reagent:	MO1-ppm1g
Anatomical Term:	brain
Stage:	Long-pec

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	WT + MO1-ppm1g
Knockdown Reagent:	MO1-ppm1g
Observed In:	central nervous system forebrain ventricular zone head presumptive telencephalon proctodeum
Stage Range:	Prim-5 to Prim-25

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dev. Dyn.